No Data
N2OFF to Acquire Biotech Firm MitoCareX Bio; Shares Fall
Express News | N2OFF To Acquire MitoCareX Bio From $SciSparc; To Acquire $4,961 Sgares From $700,000
N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers
N2OFF Will Purchase 4,961 Shrs From SciSparc for $700,000 and Exchange Additional Shrs With All Sellers Totaling 40% of the Company's Stk >NITO
Express News | N2off Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard to Treat Cancers
Express News | Scisparc Ltd: As Part of Settlement, Co Is Entitled to $411,000 Payment From Defendants for Full Dismissal by Co of Alleged Claims
